No abstract available
MeSH terms
-
Administration, Topical
-
Adrenergic alpha-Agonists / administration & dosage
-
Adrenergic alpha-Agonists / therapeutic use
-
Amines / administration & dosage
-
Amines / therapeutic use
-
Analgesics / administration & dosage
-
Analgesics / therapeutic use*
-
Boronic Acids / adverse effects*
-
Boronic Acids / therapeutic use
-
Bortezomib
-
Clonidine / administration & dosage
-
Clonidine / therapeutic use
-
Cyclohexanecarboxylic Acids / administration & dosage
-
Cyclohexanecarboxylic Acids / therapeutic use
-
Drug Combinations
-
Excitatory Amino Acid Antagonists / administration & dosage
-
Excitatory Amino Acid Antagonists / therapeutic use
-
Gabapentin
-
Gels
-
Humans
-
Ketamine / administration & dosage
-
Ketamine / therapeutic use
-
Male
-
Middle Aged
-
Pain Measurement
-
Paraproteinemias / complications
-
Peripheral Nervous System Diseases / chemically induced*
-
Peripheral Nervous System Diseases / drug therapy*
-
Protease Inhibitors / administration & dosage
-
Protease Inhibitors / therapeutic use*
-
Pyrazines / adverse effects*
-
Pyrazines / therapeutic use
-
Walking
-
gamma-Aminobutyric Acid / administration & dosage
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
Adrenergic alpha-Agonists
-
Amines
-
Analgesics
-
Boronic Acids
-
Cyclohexanecarboxylic Acids
-
Drug Combinations
-
Excitatory Amino Acid Antagonists
-
Gels
-
Protease Inhibitors
-
Pyrazines
-
gamma-Aminobutyric Acid
-
Ketamine
-
Bortezomib
-
Gabapentin
-
Clonidine